NanoGroup S.A. (WSE:NNG)

Poland flag Poland · Delayed Price · Currency is PLN
2.665
-0.030 (-1.11%)
Oct 10, 2025, 4:42 PM CET
-1.11%
Market Cap85.72M
Revenue (ttm)100.00
Net Income (ttm)-7.00M
Shares Out32.16M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume46,162
Average Volume48,271
Open2.690
Previous Close2.695
Day's Range2.600 - 2.690
52-Week Range2.060 - 4.100
Beta0.74
RSI46.25
Earnings DateSep 19, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.

Financial Statements

News

There is no news available yet.